Patent

Congratulations to Dr. Aimee Ryan (McGillU), Dr. Makoto Nagano (McGillU), and Dr. Enrique Gamero Estévez for their US patent approval titled “CLAUDIN-TARGETING AGENTS AND USES THEREOF”.  

• Patent No.: “17/073,817”  
• These agents transiently disrupt the cell-cell junctions and allow for an efficient delivery of cells and compounds.